HIV gp41 vaccine - Panacos
Latest Information Update: 15 Apr 2008
At a glance
- Originator Panacos Pharmaceuticals
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 20 Mar 2001 The vaccine is available for licensing (http://www.panacos.com)
- 20 Mar 2001 Preclinical development for HIV-1 infections in USA (Unknown route)